China News Service, November 18, according to Euronet citing EUN News Agency, the Chinese Embassy in Italy issued a warm reminder on the 17th to be wary of illegal new crown pneumonia vaccines.
Local media in Rome reported on the 17th that recently, some family doctors in Rome discovered that many people, including Italians, were "privately using a new crown pneumonia vaccine."
It is reported that the vaccine is still undergoing phase III clinical trials.
Some family doctors in Rome reported to the Rome Doctors’ Association that it is still impossible to determine the source of these vaccines.
The family doctor said that even the real new coronary pneumonia vaccine must be strictly controlled in accordance with the test requirements and cannot be purchased and injected privately.
Antonio Magi, president of the Association of Doctors in Rome, warned that no one should buy vaccines of unknown origin privately or through the black market.
Moreover, the Italian health authorities have not yet approved any vaccine to circulate on the market, and all new coronary pneumonia vaccines in the world are currently in clinical trials or approved for emergency applications.
Only under the strict supervision of the medical system can the safety of vaccine recipients be ensured.
McGee said that the association is currently collecting some information and evidence of the new crown pneumonia vaccine from unknown sources on the black market, and will promptly notify the police and the Italian Drug Administration (AIFA).
The police have stated that they will severely crack down on illegal smuggling and the use of COVID-19 vaccines of unknown origin.
To this end, he hopes that people will patiently wait for the vaccine approved by the State Drug Administration to avoid the danger of vaccination of vaccines of unknown origin.
On the 17th local time, the Chinese Embassy in Italy issued a warm reminder on its official website and official accounts on social media platforms to be wary of illegal new crown pneumonia vaccines. Recently, some Italian media reported and paid attention to the possibility of irregular or counterfeit new crown pneumonia vaccines in Italy.
In order to safeguard the health, safety, legal rights and good image of the overseas Chinese in Italy, the Chinese Embassy in Italy would like to remind everyone:
1. Accurately understand the progress of vaccine research and development.
China's new crown pneumonia vaccine research and development is generally in a leading position in the world, and some vaccines are undergoing phase III clinical trials.
At present, emergency use is only implemented in China on a voluntary basis and no vaccine has been approved for marketing.
The Italian government and institutions have not cooperated with the Chinese vaccine research and development team and production companies.
Vaccine research and development in other countries are also in different stages of clinical trials and have not yet been approved for marketing.
2. Be highly vigilant against the harm of illegal vaccines.
The production, storage and transportation of the new crown pneumonia vaccine require strict conditions and special equipment, and the vaccination and injection must be operated by specialized agencies and professionals.
Any vaccine obtained through informal channels or inoculated by non-professionals will harm personal health and even life safety.
3. Strictly abide by local laws and regulations.
Up to now, the Italian government has not approved any new coronary pneumonia vaccines to be marketed, and only a few institutions are authorized to strictly conduct vaccine clinical trials.
No institution or person is allowed to buy, sell, store, or use informal channels for the new coronary pneumonia vaccine.
Fourth, actively deliver correct information.
The media are very concerned about the development and use of the new coronary pneumonia vaccine and follow up and report in depth.
The vast numbers of overseas Chinese are invited to communicate about vaccination issues in a rigorous and responsible manner, and strictly distinguish between different laws, regulations and practices in China and Italy to avoid negative impacts.
(Boyuan)